Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD16 antibody

This anti-CD16 antibody is a Mouse Monoclonal antibody detecting CD16 in FACS, IP and IHC. Suitable for Human.
Catalog No. ABIN203907

Quick Overview for CD16 antibody (ABIN203907)

Target

See all CD16 Antibodies
CD16

Reactivity

  • 144
  • 31
  • 20
  • 20
  • 20
  • 9
  • 8
  • 8
  • 8
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 126
  • 28
  • 20
  • 1
Mouse

Clonality

  • 147
  • 26
  • 1
Monoclonal

Conjugate

  • 65
  • 18
  • 15
  • 13
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD16 antibody is un-conjugated

Application

  • 144
  • 35
  • 29
  • 28
  • 28
  • 24
  • 22
  • 18
  • 6
  • 6
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (IHC)

Clone

BA-1
  • Specificity

    Recognizes a sialic acid-dependent epitope of human CD24 of approximately 35/45kD.

    Purification

    Purified

    Immunogen

    Human B lymphocyte tumor cells: NALM-6-M1.

    Isotype

    IgM
  • Application Notes

    Approved: Flo, IHC, IP

    Usage: Suitable for use in Flow Cytometry, Immunoprecipitation, Immunohistochemistry.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    PBS,  pH 7.2, 5 % glycerol, 0.2 % BSA, 0.05 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    CD16

    Alternative Name

    CD16

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Chat with us!